This integrative, severity-stratified analysis identifies shared molecular and regulatory features linking severe COVID-19 with aggressive cancers, highlighting persistent immune activation and altered immune communication as common underlying themes without implying causality or clinical outcome effects. These findings provide a systems-level, hypothesis-generating framework for understanding virus-cancer interactions and may inform future biomarker discovery and immune-focused therapeutic strategies in vulnerable cancer populations.
Ahmed et al. (Wed,) studied this question.